PATIENT AND PARTNER TREATMENT SATISFACTION SCALE (TSS) IN ERECTILE DYSFUNCTION

Author(s)

Kubin M1, Britt D2, Trudeua E3, Fugl-Meyer A4, Gondek K5 , 1Bayer AG, Wuppertal, Germany; 2Bayer Pharmaceutical, West Haven, CT, USA; 3MAPI Values, Lyon, France; 4Upsala University, Upsala, Sweden; 5Bayer Pharmaceutical Corporation, West Haven, CT, USA

OBJECTIVE: To develop an instrument to assess male patient's and their female partner's satisfaction with the treatment for erectile dysfunction (ED) and assess the comprehensiveness, comprehension, acceptability and clarity of the instrument. METHODS: Four phases were performed in the questionnaire development; item generation, face and content validity, cognitive debriefing, cultural and language adaptation. Item generation was based on literature review, hypothesized characteristics of the drug and in-depth interviews with patients and their partners. Perceptions and feelings related to the condition and their expectations of treatment were examined. Items were generated simultaneously in English, French and German and adapted to each culture. Content and face validity were assessed by interviews with patients and partners in 5 countries. Testing of structure and response scales, cognitive debriefing and verification of conceptual equivalence between languages was assessed. RESULTS: A total of 55 interviews were conducted to test face and content validity for patients, partners and experts. The final content areas deemed important included spontaneity, quality of erection, quality of ejaculation, sexual pleasure, satisfaction with orgasm, confidence, reliability of treatment, side effect, convenience, overall satisfaction, conformity to treatment expectations and intentions for continued use of drug. Cognitive debriefing with patients and partners found no problems with comprehension. Results of the debriefing found some words to be problematic. There were no cultural differences found between the English, French or German version. The questionnaire was revised at each phase. The final questionnaire for both the patient and the partner contained 19 questions. The questionnaire was then translated into 14 additional languages for use in clinical trials. CONCLUSIONS: The TSS is a comprehensive measure of male ED patients and their respective partners. Further work is needed to validate the TSS, identify the domains, test the responsiveness and determine the appropriate scoring.

Conference/Value in Health Info

2003-11, ISPOR Europe 2003, Barcelona, Spain

Value in Health, Vol. 6, No. 6 (November/December 2003)

Code

PWH6

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes, Stated Preference & Patient Satisfaction

Disease

Reproductive and Sexual Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×